AM

Aziz Moqrich

Co-founder and Chief Scientific Officer (CSO)

Tafalgie Therapeutics

Therapeutic Areas

Tafalgie Therapeutics Pipeline

DrugIndicationPhase
TT5Postoperative PainPhase 1
Lead 2Chronic and Acute PainPreclinical